Home › BioMérieux Q4 Revenues Up 4 Percent

BioMérieux Q4 Revenues Up 4 Percent

Jan 23, 2018

NEW YORK (GenomeWeb) - BioMérieux reported today its fourth quarter revenues rose 4 percent year over year, with sales of BioFire FilmArray products accounting for more than half of the growth in the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
15
Featured Webinar

Next-Generation Platforms for Strain Optimization: Reducing the Cost and Time for Commercializing Novel Biological Molecules

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

What's Popular?

In Infectious Disease

  1. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  2. Abbott Q3 Dx Business Grows 43 Percent

  3. BD Obtains CE Mark for Molecular TB, MDR-TB Assay

  4. Antibiotic Resistance Monitoring Consortium Expands to Highlight Battle Against Superbugs

    Premium

  5. BioMérieux Q3 Revenues Grow 7 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.